Wondaleaf In Dubai, UAE Arab Health 2023 Overview Wondaleaf will be exhibiting at one of the largest medical device exhibitions in the region Arab Health 2023 which would be held at the Dubai World Trade Centre. What is Arab Health? Arab Health is the leading medical equipment exhibition in the Middle East showcasing the… Continue reading Wondaleaf at Arab Health 2023
FRHAM Endorses WONDALEAF UNISEX Condom fro World AIDS DaY 2021 R1: Dr Rajes, Dr John Tang, Dr Koh Kar Chai, Tengku Munazirah, Dr Kamal Kenny, Dr Alex Matthew Petaling Jaya, 11 December, 2021 – In conjunction with this year’s World AIDS Day, the Federation of Reproductive Health Associations, Malaysia (FRHAM) endorses the launch of the World’s… Continue reading FRHAM ENDORSES WONDALEAF UNISEX CONDOM
Nov. 2016. Wondaleaf was showcased to UNFPA officials in a conference at United Nation in Bangkok. The pivotal meeting also led to Wondaleaf’s clinical trial in South Africa in 2017. The functional performance study conducted by MatCH has now been completed. The favourable results will be published in due course.
The story of Wondaleaf is told in an international film documentary on innovative female condoms. We are privileged to be interviewed and glad to have the opportunity to make the new invention known to more people. Joyride is a 1 hour documentary written and produced by Randall Wood in partnership with Screen Australia, ZDF/ARTE and other… Continue reading Wondaleaf featured in an international documentary
June 2017. In addition to the grants from PlatCOM Venture Sdn Bhd of Agensi Innovasi Malaysia (RM 700,000) and Cradle Fund Sdn Bhd of Ministry of Finance (RM 500,000), Twin Catalyst Sdn Bhd is honored to receive about RM 1,800,000 grant from Ministry of Science, Technology and Innovation for continuing the work on Wondaleaf. The… Continue reading Ministry of Science, Technology and Innovation Grant
This release is current as of 20.12.2017. According to World Health Organization, annually the world has 86 million unintended pregnancies and a maternal mortality of 287,000 women, with unsafe abortion accounting for a high percentage of maternal deaths. An estimated 222 million women wish to delay or space their pregnancies but do not have access… Continue reading Why Wondaleaf?
Wondaleaf is currently undergoing clinical trials with the aim of establishing its efficacy as a barrier contraceptive, and its utility in menstrual control. These trials further have the aim of establishing the acceptability and usability of this device, and will be used in the Malaysian Device Authority, US Food and Drug Agency, Australian Therapeutic Goods Administration and… Continue reading Wondaleaf Clinical Trials
Wondaleaf was featured at IMC in 2015. The event was organised by PLATCOM VENTURES, a federal government innovation agency which funded Wondaleaf project.
On the 5th of February, 2015, the founder of Twin Catalyst and inventor of Wondaleaf, Dr. John Tang Ing Ching signed a Memorandum of Understanding (MOU) with the University College of Technology Sarawak (UCTS). The signing of the MOU signified Twin Catalyst’s first big step forward of many towards a closer partnership with local resources… Continue reading Signing of MOU with University College of Technology Sarawak